Markets:

Overview

News

Currencies

International

Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

53.22 -17.47 (-24.71%)

Streaming Delayed Price Updated: 11:31 AM EDT, Sep 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 14, 2024

Via Benzinga

LQDA Stock Earnings: Liquidia Misses EPS, Misses Revenue for Q1 2024 ↗

May 14, 2024

LQDA stock results show that Liquidia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 13, 2024

From Liquidia Corporation

Via GlobeNewswire

Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD

May 10, 2024

From Liquidia Corporation

Via GlobeNewswire

The Analyst Landscape: 5 Takes On Liquidia ↗

April 01, 2024

Via Benzinga

Unveiling 6 Analyst Insights On Liquidia ↗

March 13, 2024

Via Benzinga

Recap: iShares $ Corp Bond UCITS ETF Q4 Earnings ↗

March 13, 2024

Via Benzinga

Topics ETFs

Liquidia Corporation to Present at BofA Securities Health Care Conference 2024

May 07, 2024

From Liquidia Corporation

Via GlobeNewswire

Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024

May 07, 2024

From Liquidia Corporation

Via GlobeNewswire

Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation' ↗

April 25, 2024

"Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare. "I would buy it slowly because we've got big selling going on in AI stock Meta," he added.

Via Benzinga

Topics Artificial Intelligence

Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference

April 02, 2024

From Liquidia Corporation

Via GlobeNewswire

Liquidia Earnings Preview ↗

March 12, 2024

Via Benzinga

Decoding 5 Analyst Evaluations For Liquidia ↗

January 05, 2024

Via Benzinga

Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder

April 01, 2024

From Liquidia Corporation

Via GlobeNewswire

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 27, 2024

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday ↗

March 14, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday.

Via Benzinga

Topics Stocks

Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update

March 13, 2024

From Liquidia Corporation

Via GlobeNewswire

Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024

March 06, 2024

From Liquidia Corporation

Via GlobeNewswire

Earnings Scheduled For March 13, 2024 ↗

March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

Via Benzinga

United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings ↗

February 21, 2024

Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the implications on PH-ILD, potential 30-month stay, and recent financial...

Via Benzinga

This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate ↗

February 12, 2024

United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:

Via Benzinga

Topics Intellectual Property

Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress

January 30, 2024

From Liquidia Corporation

Via GlobeNewswire

Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder

January 25, 2024

From Liquidia Corporation

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 23, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 22, 2024

Via Benzinga

Liquidia Corporation Announces Updates to Operations Leadership

January 19, 2024

From Liquidia Corporation

Via GlobeNewswire

Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims

January 08, 2024

From Liquidia Corporation

Via GlobeNewswire

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 17, 2024

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan...

Via Benzinga

Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD

January 05, 2024

From Liquidia Corporation

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.